Causes of Ascites
Cirrhosis is the most common cause of ascites, accounting for approximately 75-85% of cases, with the remaining cases caused by conditions such as malignancy, heart failure, tuberculosis, pancreatic disease, and nephrotic syndrome. 1, 2
Classification Based on Serum-Ascites Albumin Gradient (SAAG)
The SAAG is the most useful test to determine the underlying cause of ascites, with an accuracy of approximately 97%.
High SAAG (≥1.1 g/dL) - Portal Hypertension Related
- Cirrhosis (most common cause)
- Alcoholic hepatitis
- Heart failure
- Budd-Chiari syndrome
- Portal vein thrombosis
- Massive liver metastases
- Liver involvement in right heart failure 1
Low SAAG (<1.1 g/dL) - Non-Portal Hypertension Related
- Peritoneal carcinomatosis
- Tuberculosis peritonitis
- Pancreatic ascites
- Nephrotic syndrome
- Serositis in connective tissue diseases
- Bowel obstruction or infarction 1
Pathophysiology of Ascites Formation
Two key factors are involved in the pathogenesis of ascites:
Portal hypertension: Increases hydrostatic pressure within hepatic sinusoids, favoring fluid transudation into the peritoneal cavity 1
- Progressive collagen deposition and nodule formation in cirrhosis alter normal vascular architecture
- Activated hepatic stellate cells may dynamically regulate sinusoidal tone and portal pressure
Sodium and water retention: Inability to excrete adequate sodium leads to positive sodium balance 1
- Arterial splanchnic vasodilation causes decreased effective arterial blood volume
- Activation of vasoconstrictor and sodium-retaining systems (sympathetic nervous system and renin-angiotensin-aldosterone system)
- Renal sodium retention leads to expansion of extracellular fluid volume and ascites formation
Diagnostic Approach
Initial Investigations
- Diagnostic paracentesis with:
- Ascitic fluid cell count and differential
- Total protein and albumin measurement
- SAAG calculation
- Culture (bedside inoculation into blood culture bottles)
- Neutrophil count to rule out spontaneous bacterial peritonitis 1
Additional Tests Based on Clinical Suspicion
- Amylase (if pancreatic origin suspected)
- Cytology (if malignancy suspected)
- Glucose and lactate dehydrogenase (if secondary bacterial peritonitis suspected)
- Mycobacterial culture (if tuberculosis suspected) 1
Imaging
- Abdominal ultrasound to evaluate:
- Liver appearance
- Pancreas and lymph nodes
- Presence of splenomegaly (suggesting portal hypertension) 1
Management Considerations
The treatment of ascites depends on its cause:
For Cirrhotic Ascites
- Sodium restriction (2000 mg/day)
- Diuretic therapy:
- Spironolactone (aldosterone antagonist) counteracts secondary aldosteronism 3
- Loop diuretics may be added for resistant cases
- Monitor for complications including hyperkalemia, hyponatremia, and renal impairment
For Refractory Ascites
- Large volume paracentesis with albumin infusion
- Transjugular intrahepatic portosystemic shunt (TIPS)
- Liver transplantation for eligible candidates 4, 5
For Non-Portal Hypertensive Ascites
- Treatment directed at the underlying cause
- Low SAAG ascites generally does not respond to sodium restriction and diuretics 1
Special Considerations
Alcohol-induced liver disease: Abstinence from alcohol can dramatically improve the reversible component of alcoholic liver disease and make ascites more responsive to medical therapy 1
Monitoring: Daily weight monitoring is essential to assess diuretic efficacy and prevent adverse effects; weight loss should not exceed 0.5 kg/day in patients without peripheral edema 1
Hyponatremia: Fluid restriction is generally not necessary unless severe hyponatremia is present 1
Hepatic impairment: Spironolactone can cause sudden alterations of fluid and electrolyte balance which may precipitate impaired neurological function and worsening hepatic encephalopathy 3
The development of ascites is associated with poor prognosis and impaired quality of life. Patients with cirrhosis and first onset of ascites have a probability of survival of 85% during the first year and 56% at 5 years without liver transplantation 4.